Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00009204 · ClinicalTrials.gov registry record · Phase 3

Serotonergic Pharmacotherapy for Agitation of Dementia

A Phase 3 study of Alzheimer Disease and Dementia, sponsored by Bruce Pollock.

Completed
Registry status
Phase 3
Development phase
1
Study location

NCT00009204 is a Phase 3 study of Alzheimer Disease and Dementia that has completed, run by Bruce Pollock. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00009204, a Phase 3 study of Alzheimer Disease and Dementia, has completed, sponsored by Bruce Pollock.

COMPLETED
Registry status
Phase 3
Development phase
1
Study location

Study Summary

This study is a randomized, double-blind, placebo-controlled, fixed dose study currently being conducted on two geropsychiatric units at Western Psychiatric Institute and Clinic. It seeks to evaluate the short-term safety and efficacy of citalopram and perphenazine in the treatment of 112 patients suffering from behavioral disturbances associated with dementia. Findings from this research may directly lead to improved acute pharmacotherapy for psychosis and behavioral problems in patients diagnosed with dementia. Improved treatment of behavioral complications with reduced side effects would reduce excess disability in patients diagnosed with dementia, allowing them to be maintained in the community for greater periods of time.

Conditions Studied

Alzheimer Disease Dementia Dementia, Vascular

Interventions

  • DRUG Citalopram [Celexa]
  • DRUG Perphenazine [Trilafon]

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Western Psychiatric Institute and Clinic - Pittsburgh

Trial Details

FieldValue
Start Date 1995-09
Est. Completion 2002-04
Phase Phase 3

Sponsor

Bruce Pollock

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00009204

The ClinicalTrials.gov registry entry for NCT00009204 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Bruce Pollock, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Citalopram [Celexa] is the first listed.

NCT00009204 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00009204 about?

NCT00009204 is a clinical study titled "Serotonergic Pharmacotherapy for Agitation of Dementia". This study is a randomized, double-blind, placebo-controlled, fixed dose study currently being conducted on two geropsychiatric units at Western Psychiatric Institute and Clinic. It seeks to evaluate the short-term safety and efficacy of citalopram and perphenazine in the treatment of 112 patients s...

What is the current status of trial NCT00009204?

This trial is currently completed. It is a Phase 3 study. The study started on 1995-09. Estimated completion is 2002-04.

What conditions does trial NCT00009204 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Dementia, Vascular.

What interventions are being tested in trial NCT00009204?

The interventions under investigation include: Citalopram [Celexa] (DRUG), Perphenazine [Trilafon] (DRUG).

Who is sponsoring clinical trial NCT00009204?

This trial is sponsored by Bruce Pollock, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00009204 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Dementia

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.